Karen A. Briggs

FDA investigator

Appears on 19 documents from 2021 to 2026, most often at sites in Virginia. Most often cites design and construction features (21 CFR 211.42).

19
Documents on file
5.3
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 106 observations

Activity by year

2021: 2, 2022: 2, 2023: 5, 2024: 2, 2025: 5, 2026: 3

Where

Virginia 4 · France 3 · New Jersey 3 · Pennsylvania 3 · India 2 · China 1

Is Karen A. Briggs coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

19 documents, newest first
FirmOpen
483 Jiangsu Hansoh Pharmaceutical Group Co. Ltd. No 5. Dongjin Road, Economic and Technical Development ZoneApr 24, 2026 · Lianyungang, China
Warning letter Excel VisionJan 22, 2026 · Annonay, France
483 Excel VisionJan 22, 2026 · Annonay, France
483 Baxter Onocology GmbHSep 26, 2025 · Halle (Westf.), Germany
483 Fareva AmboiseSep 16, 2025 · Poce Sur Cisse, France
483 Granules India LimitedJun 20, 2025 · Sangareddy, India
483 Fareva Richmond, Inc.May 23, 2025 · Henrico, Virginia

About this profile

What does Karen A. Briggs inspect?

Karen A. Briggs appears on 19 documents on file covering 16 sites, most often in Virginia.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.67 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Karen A. Briggs is dated Apr 24, 2026.